AI Drug Discovery

July 18, 2022
AIMS, Academic Research, AI Drug Discovery

Atomwise scientists are using machine learning to help University of Alberta researchers find compounds that have the potential to regrow damaged nerves. Nerve damage is a common problem following injury in neurological disorders, but regrowing […]

Read Article
July 11, 2022
AI Technology, AI Drug Discovery

Our scientists developed AtomNet® PoseRanker to improve our technology’s ability to rank poses for protein-ligand interactions with potential drug compounds Identifying the highest-quality protein-ligand poses generated from structure-based virtual […]

Read Article
June 27, 2022
AI Technology, AI Drug Discovery

Our scientists have developed a set of chemical benchmarks to better understand exactly what our computational models are learning. At Atomwise, AtomNet® structure-based models can quickly identify active compounds for protein targets from large […]

Read Article
February 28, 2022
AI Technology, AI Drug Discovery

 Atomwise scientists are adapting machine learning models to make predictions about a class of drug compounds that has been challenging to study.

Read Article
January 25, 2022
AI Technology, AtomNet, AI Drug Discovery

Our researchers are developing an automated pipeline that can more accurately identify promising compounds targeting multi-site proteins

Read Article
September 15, 2020
AIMS, Academic Research, AI Drug Discovery

With the implementation of genomic technologies, medicine is becoming increasingly personalized thanks to new treatments that target important molecular targets. In the context of Parkinson's disease, there is an urgent need to identify molecular […]

Read Article

Subscribe

Stay up to date on new blog posts.

Atomwise needs the contact information you provide to send you updates. You may unsubscribe from these communications at any time. For information please review our Privacy Policy.